ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation

Abstract Propofol and midazolam are the current standard of care for prolonged sedation in Intensive Care Units (ICUs). However, the effects and mechanism of these sedatives in brain tissue are unclear. Herein, the development of an ICU patient-on-a-chip platform to elucidate those effects is report...

Full description

Saved in:
Bibliographic Details
Main Authors: Pelin Saglam-Metiner, Sena Yanasik, Yusuf Caglar Odabasi, Jennifer Modamio, Moritz Negwer, Cigir Biray-Avci, Ayse Guler, Ali Erturk, Ender Yildirim, Ozlem Yesil-Celiktas
Format: Article
Language:English
Published: Nature Portfolio 2024-12-01
Series:Communications Biology
Online Access:https://doi.org/10.1038/s42003-024-07313-z
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850169402081673216
author Pelin Saglam-Metiner
Sena Yanasik
Yusuf Caglar Odabasi
Jennifer Modamio
Moritz Negwer
Cigir Biray-Avci
Ayse Guler
Ali Erturk
Ender Yildirim
Ozlem Yesil-Celiktas
author_facet Pelin Saglam-Metiner
Sena Yanasik
Yusuf Caglar Odabasi
Jennifer Modamio
Moritz Negwer
Cigir Biray-Avci
Ayse Guler
Ali Erturk
Ender Yildirim
Ozlem Yesil-Celiktas
author_sort Pelin Saglam-Metiner
collection DOAJ
description Abstract Propofol and midazolam are the current standard of care for prolonged sedation in Intensive Care Units (ICUs). However, the effects and mechanism of these sedatives in brain tissue are unclear. Herein, the development of an ICU patient-on-a-chip platform to elucidate those effects is reported. The humanized neural tissue compartment combines mast cells differentiated from human induced pluripotent stem cells (hiPSCs) with cerebral organoids in a three-dimensional (3D) matrix, which is covered with a membrane populated with human cerebral microvascular endothelial cells (hCMEC/D3) that separates the tissue chamber from the vascular lumen, where sedatives were infused for four days to evaluate neurotoxicity and cell-mediated immune responses. Subsequent to propofol administration, gene expressions of CD40 and TNF-α in mast cells, AIF1 in microglia and GFAP/S100B/OLIG2/MBP in macroglia were elevated, as well as NOS2, CD80, CD40, CD68, IL6 and TNF-α mediated proinflammation is noted in cerebral organoids, which resulted in higher expressions of GJB1, GABA-A and NMDAR1 in the tissue construct of the platform. Besides, midazolam administration stimulated expression of CD40 and CD203c+ reactivated mast cell proliferation and compromised BBB permeability and decreased TEER values with higher barrier disruption, whereas increased populations of CD11b+ microglia, higher expressions of GFAP/DLG4/GJB1 and GABA-A-/NMDAR1- identities, as well as glutamate related neurotoxicity and IL1B, IFNG, IFNA1, IL6 genes mediated proinflammation, resulting in increased apoptotic zones are observed in cerebral organoids. These results suggest that different sedatives cause variations in cell type activation that modulate different pathways related to neuroinflammation and neurotoxicity in the ICU patient-on-chip platform.
format Article
id doaj-art-cffa6642360845c3b48947e64eb7d508
institution OA Journals
issn 2399-3642
language English
publishDate 2024-12-01
publisher Nature Portfolio
record_format Article
series Communications Biology
spelling doaj-art-cffa6642360845c3b48947e64eb7d5082025-08-20T02:20:44ZengNature PortfolioCommunications Biology2399-36422024-12-017111910.1038/s42003-024-07313-zICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammationPelin Saglam-Metiner0Sena Yanasik1Yusuf Caglar Odabasi2Jennifer Modamio3Moritz Negwer4Cigir Biray-Avci5Ayse Guler6Ali Erturk7Ender Yildirim8Ozlem Yesil-Celiktas9Department of Bioengineering, Faculty of Engineering, Ege UniversityDepartment of Bioengineering, Faculty of Engineering, Ege UniversityDepartment of Bioengineering, Faculty of Engineering, Ege UniversityInstitute for Tissue Engineering and Regenerative Medicine (iTERM), Helmholtz Zentrum MünchenInstitute for Tissue Engineering and Regenerative Medicine (iTERM), Helmholtz Zentrum MünchenDepartment of Medical Biology, Faculty of Medicine, Ege University, BornovaDepartment of Neuroscience, Faculty of Medicine, Ege University, BornovaInstitute for Tissue Engineering and Regenerative Medicine (iTERM), Helmholtz Zentrum MünchenDepartment of Mechanical Engineering, Middle East Technical UniversityDepartment of Bioengineering, Faculty of Engineering, Ege UniversityAbstract Propofol and midazolam are the current standard of care for prolonged sedation in Intensive Care Units (ICUs). However, the effects and mechanism of these sedatives in brain tissue are unclear. Herein, the development of an ICU patient-on-a-chip platform to elucidate those effects is reported. The humanized neural tissue compartment combines mast cells differentiated from human induced pluripotent stem cells (hiPSCs) with cerebral organoids in a three-dimensional (3D) matrix, which is covered with a membrane populated with human cerebral microvascular endothelial cells (hCMEC/D3) that separates the tissue chamber from the vascular lumen, where sedatives were infused for four days to evaluate neurotoxicity and cell-mediated immune responses. Subsequent to propofol administration, gene expressions of CD40 and TNF-α in mast cells, AIF1 in microglia and GFAP/S100B/OLIG2/MBP in macroglia were elevated, as well as NOS2, CD80, CD40, CD68, IL6 and TNF-α mediated proinflammation is noted in cerebral organoids, which resulted in higher expressions of GJB1, GABA-A and NMDAR1 in the tissue construct of the platform. Besides, midazolam administration stimulated expression of CD40 and CD203c+ reactivated mast cell proliferation and compromised BBB permeability and decreased TEER values with higher barrier disruption, whereas increased populations of CD11b+ microglia, higher expressions of GFAP/DLG4/GJB1 and GABA-A-/NMDAR1- identities, as well as glutamate related neurotoxicity and IL1B, IFNG, IFNA1, IL6 genes mediated proinflammation, resulting in increased apoptotic zones are observed in cerebral organoids. These results suggest that different sedatives cause variations in cell type activation that modulate different pathways related to neuroinflammation and neurotoxicity in the ICU patient-on-chip platform.https://doi.org/10.1038/s42003-024-07313-z
spellingShingle Pelin Saglam-Metiner
Sena Yanasik
Yusuf Caglar Odabasi
Jennifer Modamio
Moritz Negwer
Cigir Biray-Avci
Ayse Guler
Ali Erturk
Ender Yildirim
Ozlem Yesil-Celiktas
ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
Communications Biology
title ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
title_full ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
title_fullStr ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
title_full_unstemmed ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
title_short ICU patient-on-a-chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
title_sort icu patient on a chip emulating orchestration of mast cells and cerebral organoids in neuroinflammation
url https://doi.org/10.1038/s42003-024-07313-z
work_keys_str_mv AT pelinsaglammetiner icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT senayanasik icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT yusufcaglarodabasi icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT jennifermodamio icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT moritznegwer icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT cigirbirayavci icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT ayseguler icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT alierturk icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT enderyildirim icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation
AT ozlemyesilceliktas icupatientonachipemulatingorchestrationofmastcellsandcerebralorganoidsinneuroinflammation